Novartis, an innovative healthcare products company with pharmaceutical treatments for heart disease, high blood pressure, diabetes, parkinsons, alzheimers, infectious disease and cancer.

Message from CEO of Novartis South Africa (Pty) Ltd.

Glen Sullivan Welcome to our new Novartis South Africa Website. More ›

Glen Sullivan
Executive Director

Novartis Feature

Novartis is persuing legal action in India

Novartis in the fight against malaria

April 25 is World Malaria Day, an opportunity to reflect on the progress made in finding sustainable solutions for malaria. More ›

Novartis Mission

We want to discover, develop and successfully market innovative products to prevent and cure diseases, to ease suffering and to enhance the quality of life. We also want to provide a shareholder return that reflects outstanding performance and to adequately reward those who invest ideas and resources in our company.

Latest News

January 25, 2012 Novartis delivers strong underlying financial performance in 2011, expects 2012 sales to be in line with 2011	January 20, 2012 CHMP recommends EU approval to update Novartis drug Glivec® label to include three year treatment for GIST patients after surgery
January 20, 2012 Novartis drug Signifor® recommended by CHMP for EU approval to treat patients with Cushing's disease	January 19, 2012 Sandoz initiates two more Phase III biosimilar trials, reinforcing long-term global leadership commitment

USA • Switzerland • Germany • France • United Kingdom